Pharmacokinetics of rifabutin.
We investigated the pharmacokinetics of rifabutin in 15 male patients as part of a phase I trial of the treatment of early symptomatic human immunodeficiency virus infection. Six or more patients were studied at each of four different oral dosage levels: 300, 600, 900, and 1,200 mg/day. Twelve studi...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1989
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172632/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2552902/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.8.1237 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|